Smartphones, sports injury, and stories about science: This week in our Children’s Hospital of Philadelphia research roundup, 2018 is in full swing as our investigators made media headlines for their work to advance children’s health. Keep reading to learn about the different ways researchers at CHOP study the benefits and drawbacks of teens’ smartphone use, why research led by concussion experts at our Center for Injury Research and Prevention (CIRP) was featured in a recent philly.com article, and how experts in the Mitochondrial Medicine Frontier Program are weighing in on vitamins and supplements for mitochondrial disease.
Tag Archive: Douglas Wallace
After a year of huge headlines for children’s health, we’ve finally arrived at our last roundup of Children’s Hospital of Philadelphia research news for 2017. The latest developments cap off a benchmark year of discovery, with new advances in treating childhood blindness, novel initiatives to study traumatic brain injury, and wonderful stories from a variety of media outlets that highlight the efforts and accomplishments of our Mitochondrial Medicine Frontier Program and The Raymond G. Perelman Center for Cellular and Molecular Therapeutics. We think this edition’s collection of news items herald exciting things to come in 2018!
It was a big year for children’s health: We celebrated the U.S. Food and Drug Administration’s approval of the world’s first chimeric antigen receptor (CAR)-T cell therapy this September, followed closely by approval of the very first gene therapy to treat inherited blindness this month — both of which have their roots at Children’s Hospital of Philadelphia and the University of Pennsylvania. But besides the big headline-making breakthroughs (brilliant as they are), we wanted to know what other stories captivated our readers in 2017.
September marks National Childhood Cancer Awareness Month, and this year at Children’s Hospital of Philadelphia, we kick-started the commemorative period on the heels of exciting news about breakthroughs in pediatric cancer immunotherapy research. Oncology investigators at CHOP also got a big boost in research funding from Hyundai’s nonprofit organization, Hope on Wheels. And that’s only the beginning: Since September marks the return of the football season, we’re thrilled to share the latest headlines on how the National Football League (NFL) is helping to drive concussion research.
Differences in mitochondrial function are a major factor in understanding the origins of autism spectrum disorders (ASD), according to a new study led by Douglas Wallace, PhD, director of the Center for Mitochondrial and Epigenomic Medicine at Children’s Hospital of Philadelphia, that points way back to genetic vulnerabilities accumulated during ancient human migrations.
Like the mitochondria that Douglas Wallace, PhD, has dedicated his scientific career to studying, energy keeps building about his exciting work. Dr. Wallace’s latest high-profile achievement is being selected as the recipient of the Dr. Paul Janssen Award for Biomedical Research.
A march, a medal, and a media blitz: In this week’s research news, Children's Hospital of Philadelphia investigators made their mark in the history of progressive science in big, bold ways.
Buckle your seatbelts because this has been a busy week for research news at Children’s Hospital of Philadelphia.
Yippee! Hooray! Woo-hoo! We’d like to take a few moments to celebrate the recent accolades given to scientists and physician researchers at The Children’s Hospital of Philadelphia Research Institute who are featured in the latest issue of Bench to Bedside, our monthly newsmagazine.
Welcome back to another weekly roundup of research news from The Children’s Hospital of Philadelphia! As we head into Memorial Day weekend in the U.S. and the informal start to summer, let’s begin with news this week that resonates with some of the things we love about summer.